Novartis AG Analysis
| Analyst Ratings |
|
Average Target Price
|
104.25
|
|
Average Rating
|
3.71
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
1.57
|
0.00
|
-1.57
|
-100.00%
|
|
2022-12-31
|
1.37
|
0.00
|
-1.37
|
-100.00%
|
|
2022-09-30
|
1.55
|
1.58
|
0.03
|
1.94%
|
|
2022-06-30
|
1.50
|
1.56
|
0.06
|
4.00%
|
|
2022-03-31
|
1.44
|
1.46
|
0.02
|
1.39%
|
|
2021-12-31
|
1.41
|
1.40
|
-0.01
|
-0.71%
|
|
2021-09-30
|
1.65
|
1.71
|
0.06
|
3.64%
|
|
2021-06-30
|
1.53
|
1.66
|
0.13
|
8.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
4.60
|
|
2021-12-31
|
6.29
|
|
2020-12-31
|
5.78
|
|
2019-12-31
|
5.28
|
|
2018-12-31
|
5.14
|
|
2017-12-31
|
4.84
|
|
2016-12-31
|
4.73
|
|
2015-12-31
|
4.90
|
|
2014-12-31
|
5.20
|
|
2013-12-31
|
5.04
|
|
2012-12-31
|
5.26
|
|
2011-12-31
|
5.57
|
|
2010-12-31
|
5.05
|
|
2009-12-31
|
3.69
|
|
2008-12-31
|
3.58
|
|
2007-12-31
|
2.83
|
|
2006-12-31
|
3.05
|
|
2005-12-31
|
2.62
|
|
2004-12-31
|
2.34
|
|
2003-12-31
|
2.02
|
|
2002-12-31
|
1.83
|
|
1997-12-31
|
1.82
|